Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
about
Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimersShigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli.Affinity isolation and I-DIRT mass spectrometric analysis of the Escherichia coli O157:H7 Sakai RNA polymerase complex.Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome.Contribution of polyunsaturated fatty acids to Shiga toxin cytotoxicity in human renal tubular epithelium-derived cells.Urinary podocyte mRNA excretion in children with D+HUS: a potential marker of long-term outcome.Thrombotic microangiopathies: an update.Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody.Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice.Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseasesShiga-like toxins and HIV-1 'go through' glycosphingolipids and lipid rafts in renal cells.Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration.A glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of shiga toxin 2.Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement.Endothelial cells and thrombotic microangiopathy.A novel murine infection model for Shiga toxin-producing Escherichia coli.Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.Hemorrhagic Stroke in an Adolescent Female with HIV-Associated Thrombotic Thrombocytopenic PurpuraA diagnosis of haemolytic-uraemic syndrome blurred by alcohol abuse.Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control studyCampylobacter-Associated Hemolytic Uremic Syndrome Associated with Pulmonary-Renal Syndrome.A rapid and sensitive method to measure the functional activity of Shiga toxins in human serumThe Antibiotic Polymyxin B Impairs the Interactions between Shiga Toxins and Human Neutrophils.Global expression of prophage genes in Escherichia coli O157:H7 strain EDL933 in response to norfloxacin.Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.High temperature in combination with UV irradiation enhances horizontal transfer of stx2 gene from E. coli O157:H7 to non-pathogenic E. coli.Shiga toxin-producing Escherichia coli in yaks (Bos grunniens) from the Qinghai-Tibetan Plateau, ChinaDifferent types of cell death induced by enterotoxins.Current progress in enteropathogenic and enterohemorrhagic Escherichia coli vaccines.Evaluation of enzyme immunoassays and real-time PCR for detecting Shiga toxin-producing Escherichia coli in Southern Alberta, Canada.Molecular profiling of Escherichia coli O157:H7 and non-O157 strains isolated from humans and cattle in Alberta, Canada.Urinary biomarkers of kidney diseases in HIV-infected children.Glycosphingolipid functionsThe interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?
P2860
Q24538771-7B324A80-C7B7-4710-9339-03DF4378746CQ24669689-BB8E0E05-AADB-47F9-AE99-2B9E67DD7BCAQ28594414-058F4CFA-E97F-481F-8817-93573F2AD659Q30442733-CDE0F6F7-DDD6-474A-9700-327495B4224AQ33280033-DF310A36-621F-4FC6-889A-83712F8BD870Q33310567-CA4A4AA9-DA18-4303-8776-4E924450B1F2Q33363266-49E35E9B-EE89-44D7-9343-24F929021F6FQ33364401-94B933B1-A3AE-46A9-8B08-E82A6797CB51Q33369576-FEC90A8F-3E83-43C0-A7B3-DC6EF0299DDBQ33370827-9195C16F-F6A6-4519-B173-6722A10B7DDFQ33372365-AEE8E2BB-6D31-4C86-AA2D-F33FB32D98BFQ33374370-2E10071B-DAE8-46AB-A96F-8535F37A271DQ33380705-CB758F1B-63A8-4DA0-977C-C8DF739C0D40Q33382197-32C6A52D-ECF1-4E7E-A3B3-8828EA46AF96Q33383651-5140E5DF-F38A-4D63-B283-33F0BCA03A66Q33384511-A503C6AD-EDA0-463E-96F0-966AB5B89C6DQ33389052-ECE0FA30-D1D2-4207-AFF4-730C23BA9630Q33393854-89B573A5-EA7B-4A82-8DF8-FE29F3FEBDBAQ33394010-31234E79-CCBF-4342-8360-1C1D0EAFA040Q33397517-7A18CB0D-463B-4C30-ADE1-9B486F8153A9Q33401369-149A9264-1281-44D2-97FF-9D5FA1F6F9B7Q33403695-71BE9898-FF3C-4C04-9A5A-B3660ABCD3E5Q33405717-9DDCD003-9925-4941-AFE8-3EB3DD536BC7Q33418894-15331F51-2EF9-4F8E-B6D3-D40E34C83B46Q33419491-7FEEBF89-D255-4163-A6B7-D4CE82B30F2DQ33421074-9725E5EA-CF57-40FA-AA90-98705C627BB4Q33423056-ACCF3DB9-3F64-46BB-8903-C253173C9915Q33427445-8613D5F0-A1C6-4363-B1EE-DFFE7732124CQ33428611-0F9B8D14-CAD4-4BA8-8FBA-3AC09D5824C0Q33856818-0633AD00-E260-4C34-BC21-E014A6B3D093Q33883354-4EA91C5C-7136-48D0-86ED-31469AA38C08Q34162781-D627789F-685E-4747-838A-378C9B54B333Q34775764-8B709260-20C2-4163-A976-E3DAC5A1D21FQ35155921-173DBCA7-8119-41BC-B11C-8F39D340B425Q35193511-2AF5E1D0-FE6F-42E9-BC0F-04E47B3BE629Q35331035-6302F6D2-BF5F-4CF5-9B7E-56B0CB60C257Q35331334-27F1162A-A873-4666-B62C-34937BF20ADFQ35934081-1509ACCA-9602-49D8-A3A9-4B9D7D238ACBQ37873655-ED6ECF07-096C-4730-AD62-5C8CC0E248B3Q38022246-B5F4EE51-CBA2-40B3-9ED0-E1B4424B4928
P2860
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@ast
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@en
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@nl
type
label
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@ast
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@en
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@nl
prefLabel
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@ast
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@en
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@nl
P356
P1433
P1476
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
@en
P2888
P304
P356
10.1007/S004670100660
P577
2001-10-01T00:00:00Z
P5875
P6179
1041401019